VP, Head of Quality

Kelly O’Hare

Currently the VP, Head of Quality at Lykan Biosciences, Kelly oversees the Quality Assurance and Quality Control functions. As a Quality Executive Kelly has over 25 years of experience in various stage biopharmaceutical companies including biologics, small molecules, cell and gene therapies and diagnostic imaging agents, at both Product based companies and CDMOs.

Her direct global agency experience includes US and EMA, as well as other international agency experience. while supporting global quality operations.

What inspires Kelly is leading initiatives and teams to establish a strong, capable Quality presence focused on Quality Culture, Compliance and Data-driven Risk Assessments. She is a champion of quality by design and continuous improvement as well as efficient Quality Management Systems that support all aspects of Quality Operations, from Supply Chain through to Quality & Manufacturing within the Lykan organization as well as with our Clients and suppliers.

Prior to joining Lykan Bioscience, she held various senior leadership roles in various Quality disciplines with Solid Biosciences, OvaScience, Lantheus Medical Imaging, Vertex, Shire, and Lonza.

Kelly is a proud contributor to the commercialization of three novel products, is a supporter of future women leaders in STEM, and member of the Industry Advisory Board for the Northeastern University College of Science Biotechnology program.